PARLIAMENTARY DEBATE
Vaccine Roll-out - 21 January 2021 (Commons/Commons Chamber)
Debate Detail
I am glad to report to the House that we have now given more than 5 million doses of the vaccine across the UK to 4.6 million people. We are making good progress towards our goal of offering everyone in priority groups 1 to 4 their first dose by 15 February. That is a huge feat, and one in which we can all take pride. We are vaccinating at a greater daily rate than anywhere in Europe—twice the rate of France, Spain or Germany.
The first 5 million doses are only the beginning. We are opening more sites all the time in cathedrals, food courts, stadiums, conference centres, GP surgeries and many, many other places. Today, a cinema in Aylesbury, a mosque in Birmingham and a cricket club in Manchester have all come on board as part of 65 pharmacy-led sites across England that are joining our vaccination programme this week. That ongoing expansion will help us protect even more of the most vulnerable even quicker. From today, we will also publish more localised, granular data, broken down by NHS sustainability and transformation partnership area, as well as by region, so that the public have the best possible information about all this work.
This virus is a lethal threat to us all. As we respond through this huge endeavour, let us all take comfort in the fact that we are giving 200 vaccinations every minute. In the meantime, everyone must follow the rules to protect the NHS and save lives. We can do that safe in the knowledge that the tide will turn and that, with science, we will prevail.
In my part of rural East Sussex, the vaccine has been slow to reach rural Rother, Battle and Heathfield residents. In the 200 square miles that I represent, only one surgery has been vaccinating. That has got better from this week, and I welcome that. I thank the Sussex Community NHS Foundation Trust team. Adam Doyle and his team have been amazing to MPs.
I have three questions to the Secretary of State about rural areas. First, can we draw up a new vaccine contract for GPs that guarantees that they will receive only AstraZeneca, and not Pfizer, which they find difficult to store? Many GPs in my area tell me that they will sign the contract if they can get AstraZeneca only, so it would be just like the pharmacy contract.
Secondly, we will soon have the welcome challenge of delivering the vaccine to priority groups 5 to 9. At the same time, we will have to deliver the second dose to the priority 1 to 4 cohort, who are more vulnerable. Can we ensure that the latter priority groups go to the hubs, because those groups will find it easier to travel, and that we use our local GP surgeries to re-dose priority groups 1 to 4?
Thirdly, I know that the Government rely on the manufacturers for supplies, but can we try to give more forward-looking supply levels to our county teams so that they have indicative estimates to enable them to plan better on the ground?
I welcome the statement from the Government. I would ask that colleagues be given an opportunity every week to question members of the Government. We receive updates from our own community teams, and it is surely right that we should be able to put the same questions and ideas to the Front Benchers.
On the substance of the questions asked by my hon. Friend the Member for Bexhill and Battle (Huw Merriman), the first thing I would say is that I am absolutely delighted that there are new centres opening in Sussex—in Ticehurst village hall this week—so that the roll-out can reach all parts. I will consider the point that he makes about cohorts 5 to 9, which will need the first dose of the vaccine at the same point as we start the second dose for those who have been vaccinated from the start of January. When we restart with the second doses, it will be important to make sure that they are available as close as possible to the largely elderly population who will need them, and I will take away the point that he raises.
The challenge on the contract is tied in with the first and third of my hon. Friend’s questions. The challenge is essentially that we have a lumpy supply. The manufacturers are working incredibly hard to deliver the supply as fast as possible, and I pay tribute to them and their work. It is challenging, however, and therefore it is not possible to give certainty as far out as many GPs and those who are delivering on the ground would like. The worst thing would be to give false certainty. We do try to give information about what is coming next week, but until the supply smooths out, as I am sure it will over time, going further out than that would give false certainty. The worst thing would be to have GPs across the country booking in large numbers of people and having to reschedule those appointments unnecessarily.
I will take into account the point that the Oxford-AstraZeneca vaccine is easier to deliver in rural areas, and the request for some people to be able to do that. At the moment, however, we must use the contract that we have.
Today we have had the latest Imperial survey, and the findings are alarming. It is especially concerning that infection rates are so high in London, and yet London and the east of England appear to be behind the rest of the country on vaccine roll-out. Will he tell us what action is being taken to speed up vaccination across London and the east of England? The Imperial survey also highlights the disproportionate infection rates among key workers and those from black, Asian and minority ethnic backgrounds. Once the nine priority groups are vaccinated, is it the Secretary of State’s expectation that we will then move to prioritise key workers—teachers, police officers, firefighters, transport workers, supermarket staff—who are more exposed to the virus at the moment?
The Secretary of State will know that there are 11,000 community pharmacists. That could mean up to 30,000 pharmacists at the heart of delivering this vaccine. We should be using them not just because of the volumes of doses they can administer, but because they have years of experience of building trust and vaccine acceptability within hard-to-reach groups and minority ethnic communities. I was speaking to pharmacists this week in Dudley who were telling me this. They also, by the way, raised concerns about the wider supply of the consumables needed to administer the vaccine. Can he guarantee that there will be no delay or shortages in the delivery of this wider kit?
The new variants remind us that we have to go further and faster on vaccination and work harder to break transmission chains. Early analysis suggests the South African B1351 variant brings a reinfection risk that means vaccines may need to be redesigned. Has the Secretary of State got a contingency plan in place?
Finally, yesterday’s death numbers were truly horrific. Vaccination has to go hand in hand with measures to suppress this virus. That means further containment measures. Not everybody can work at home comfortably or isolate themselves. The system is still expecting families to go hungry to stop spreading infection. Can I urge the Secretary of State again to fix sick pay and give people proper financial support so that they can isolate and we can drive infection rates down?
The hon. Gentleman raises the question of pharmacies and, absolutely, pharmacies are going to be incredibly important, especially for reaching into those communities that may be otherwise harder to reach. The NHS as a whole is highly respected and trusted in all communities of this country so is well placed to do that, and pharmacy colleagues within the NHS particularly so, because they are often the closest to their communities. As I have set out, we have opened 65 vaccination centres that are pharmacy-led this week, with more to come.
The hon. Gentleman asks about the elderly residents of care homes. I am delighted to say that 63% of residents those or have now received the vaccination. That is a really significant increase over the last week. We are on track to deliver on our goal of vaccinating elderly care home residents by the end of this month, and I hope sooner than that.
Finally, the hon. Gentleman asks about the question of the need—potential need—for vaccine redesign if there is a new variant that is not effectively dealt with by these vaccines. Obviously, we are vigilant on that and keep it under close review. I am glad to say that the early indications are that the new variant is dealt with by the vaccine just as much as the old variant, but of course we are vigilant on the new variants we are seeing overseas. He mentioned the South Africa variant, and there is also a variant of concern that was first identified in Brazil, and of course we are vigilant on those matters, too.
What I would say in summary is that all of these things just support the need for everybody to follow the rules and stay at home. It is critical that everybody does their bit to try to stop the spread of this virus while we get the numbers under control and bring them down, thus protecting the NHS and getting this death toll down, because it is far too high.
The exact order within that queue is for a local area to decide, and sometimes people might get invited to two different methods of vaccination, such as at one of the big sites and by their local GP, and for people who are housebound there are roving teams led by the local primary care networks to get out and vaccinate them. So the offer will come, and people should be assured that while, as of today, around two thirds of all over-80s have been vaccinated—which is very, very good progress—that means there is a third still to go, and we will get to everyone and make sure everyone gets that offer to be vaccinated by 15 Feb.
On my hon. Friend’s specific question about travel and the link to vaccination, it is too early to have a firm view, because we have to see the impact of vaccination on the transmission of the disease. Obviously, when someone is vaccinated, that event goes into their health record, which is held by the NHS; it is recorded so they can demonstrate that they have been vaccinated if need be. However, for the time being, we are being very cautious on travel because of the risk of new variants, especially if there are new variants where the efficacy of the vaccine is lower.
Across Derbyshire there have been more 70,000 vaccinations—70,332, according to the latest data I have, as of 17 January. Derbyshire has vaccinated 65% of its over-80s, which is almost exactly the national average of 67%. Derbyshire is doing a great job; I congratulate those in the NHS in Derbyshire, and thank them for their efforts and their work. There is still a lot further to go, but almost two thirds of Derbyshire’s over-80s have been vaccinated. We have to keep at it and keep working hard to make sure that all the vulnerable are protected, and then move on to the rest of us.
We are sending more doses to the areas that have made the least progress so far, to make sure that by 15 February we get that offer to everybody equally, irrespective of where they live, across England for the English NHS and, indeed, we are working with the devolved Administrations to make sure that that offer is delivered fairly right across the UK. There is prioritisation of the areas that have made least progress so far, and I am working with NHS colleagues to make sure that that is done as fairly and effectively as possible.
The Secretary of State will know that the key to maximising the uptake of a vaccine is the assurance of its efficacy, but also that if people take part, it will enable life to return to normal—it will enable schools and business to reopen and family life, particularly for elderly relatives either at home or in care homes, to be restored. The public need that hope, yet while we hear much positivity, we also hear of long-term restrictions of many aspects of what was, and should again be, normal life. Can the Health Secretary give an assurance that he will provide leadership on the public messaging and its tone, and set out a route map for the return of the liberty and freedoms that we once enjoyed, and want to enjoy again?
We have to watch the data. Of course I want to see the number of cases come down, but the reason why that matters so much is that we want to see the number of hospitalisations come down. We want fewer people to die each day from this dreadful disease. The numbers published yesterday—more than 1,800 people died—were truly terrible, and we need to make sure we protect life.
Let me turn to two further matters. Would my right hon. Friend consider ensuring that all hospitals be allowed to have supplies to vaccinate their employees, because at the moment national health service employees working in hospitals are still having to travel far too far to get vaccinated? And when the priority groups have been addressed, will my right hon. Friend give particular attention to the needs of teachers, so that they can get back to work, and to the police constabulary, who are exposed every day of their working lives?
We have to ensure that the vaccination programme is fair right across the UK. Some parts of the country, including parts of the north-east and Yorkshire, have gone really fast early on, which is terrific, but we have to make sure that the vaccination programme is fair everywhere, so that everyone in the top four groups can receive that offer of a vaccine by 15 February. We will deliver on that.
On the hon. Gentleman’s point about ensuring that we have the manufacturing capability, we are investing in that capability for the medium term. We can make so much of the Oxford-AstraZeneca vaccine in the UK right now because of the work that was done with the vaccine taskforce over the summer, getting in the capability and the manufacturing. Even when the vaccine was not the major topic of discussion, we were working incredibly hard to expand UK capabilities. We took the approach that we should buy from abroad and make it here at home. It is about getting vaccine into people’s arms, no matter where it comes from, so long as it is safe and effective and does the job. That is what is happening across the whole UK.
It is really good to finish with a question from a Welsh colleague, because it demonstrates that this is a programme that can, I hope, bring the whole country together. Everybody is on the same side trying to make it happen, and we will all keep working on it together. I thank everybody involved, and I thank all colleagues for their enthusiasm and support for the vaccine roll-out programme.
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.